From GlobeNewswire: 2025-03-28 09:20:00

The global Cardiac Assist Devices Market was valued at USD 1.25 billion in 2023, projected to reach USD 2.24 billion by 2032 with a 6.06% CAGR. Increasing cardiovascular diseases, aging populations, and technological advancements are driving market growth. Companies like Abbott, Abiomed, and Medtronic are leading players in the industry.

Cardiac assist devices are crucial for heart failure management, offering mechanical support to critically ill patients. The market is growing due to a rising global burden of cardiovascular diseases and advancements in technology. The US market is experiencing significant growth, driven by an aging population and high adoption of advanced devices.

Implantable cardiac assist devices dominated the market in 2023, with a 70% share, while transcutaneous devices are seeing the highest growth. Hospitals accounted for 70% of the market in 2023, with ambulatory surgery centers emerging as the fastest-growing segment. North America leads the market, with the Asia-Pacific region expected to witness rapid growth.

Recent developments include Medtronic launching the next-gen HeartWare HVAD System, Abiomed receiving FDA approval for Impella CP 5.0, and Boston Scientific introducing the Watchman FLX Left Atrial Appendage Closure Device. These advancements aim to improve patient outcomes and reduce complications in cardiac care. Cardiovascular diseases caused 17.9 million deaths globally, emphasizing the need for effective cardiac assist devices. North America had the highest prescription rates for these devices, reflecting advanced healthcare infrastructure. The Asia Pacific region is expected to see a significant increase in device volume, aligning with rapid market growth projections. North America also led in healthcare expenditure on cardiac assist devices. The adoption rate of implantable devices was highest in developed regions, while emerging markets preferred transcutaneous devices for their non-invasive nature.



Read more at GlobeNewswire: Cardiac Assist Devices Market to Hit USD 2.24 Billion by